Christopher N Schmickl1, Jeremy E Orr2, Paul Kim3, Brandon Nokes2, Scott Sands4, Sreeganesh Manoharan2, Lana McGinnis2, Gabriela Parra2, Pamela DeYoung2, Robert L Owens2, Atul Malhotra2. 1. Division of Pulmonary, Critical Care and Sleep Medicine, University of California, San Diego (UCSD), San Diego, CA, 92037, USA. cschmickl@health.ucsd.edu. 2. Division of Pulmonary, Critical Care and Sleep Medicine, University of California, San Diego (UCSD), San Diego, CA, 92037, USA. 3. Division of Cardiology, University of California, San Diego (UCSD), San Diego, CA, 92037, USA. 4. Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: High loop gain (unstable ventilatory control) is an important-but difficult to measure-contributor to obstructive sleep apnea (OSA) pathogenesis, predicting OSA sequelae and/or treatment response. Our objective was to develop and validate a clinical prediction tool of loop gain. METHODS: A retrospective cohort of consecutive adults with OSA (apnea-hypopnea index, AHI > 5/hour) based on in-laboratory polysomnography 01/2017-12/2018 was randomly split into a training and test-set (3:1-ratio). Using a customized algorithm ("reference standard") loop gain was quantified from raw polysomnography signals on a continuous scale and additionally dichotomized (high > 0.7). Candidate predictors included general patient characteristics and routine polysomnography data. The model was developed (training-set) using linear regression with backward selection (tenfold cross-validated mean square errors); the predicted loop gain of the final linear regression model was used to predict loop gain class. More complex, alternative models including lasso regression or random forests were considered but did not meet pre-specified superiority-criteria. Final model performance was validated on the test-set. RESULTS: The total cohort included 1055 patients (33% high loop gain). Based on the final model, higher AHI (beta = 0.0016; P < .001) and lower hypopnea-percentage (beta = -0.0019; P < .001) predicted higher loop gain values. The predicted loop gain showed moderate-to-high correlation with the reference loop gain (r = 0.48; 95% CI 0.38-0.57) and moderate discrimination of patients with high versus low loop gain (area under the curve = 0.73; 95% CI 0.67-0.80). CONCLUSION: To our knowledge this is the first prediction model of loop gain based on readily-available clinical data, which may facilitate retrospective analyses of existing datasets, better patient selection for clinical trials and eventually clinical practice.
BACKGROUND: High loop gain (unstable ventilatory control) is an important-but difficult to measure-contributor to obstructive sleep apnea (OSA) pathogenesis, predicting OSA sequelae and/or treatment response. Our objective was to develop and validate a clinical prediction tool of loop gain. METHODS: A retrospective cohort of consecutive adults with OSA (apnea-hypopnea index, AHI > 5/hour) based on in-laboratory polysomnography 01/2017-12/2018 was randomly split into a training and test-set (3:1-ratio). Using a customized algorithm ("reference standard") loop gain was quantified from raw polysomnography signals on a continuous scale and additionally dichotomized (high > 0.7). Candidate predictors included general patient characteristics and routine polysomnography data. The model was developed (training-set) using linear regression with backward selection (tenfold cross-validated mean square errors); the predicted loop gain of the final linear regression model was used to predict loop gain class. More complex, alternative models including lasso regression or random forests were considered but did not meet pre-specified superiority-criteria. Final model performance was validated on the test-set. RESULTS: The total cohort included 1055 patients (33% high loop gain). Based on the final model, higher AHI (beta = 0.0016; P < .001) and lower hypopnea-percentage (beta = -0.0019; P < .001) predicted higher loop gain values. The predicted loop gain showed moderate-to-high correlation with the reference loop gain (r = 0.48; 95% CI 0.38-0.57) and moderate discrimination of patients with high versus low loop gain (area under the curve = 0.73; 95% CI 0.67-0.80). CONCLUSION: To our knowledge this is the first prediction model of loop gain based on readily-available clinical data, which may facilitate retrospective analyses of existing datasets, better patient selection for clinical trials and eventually clinical practice.
Authors: Andrey Zinchuk; Bradley A Edwards; Sangchoon Jeon; Brian B Koo; John Concato; Scott Sands; Andrew Wellman; Henry K Yaggi Journal: J Clin Sleep Med Date: 2018-05-15 Impact factor: 4.062
Authors: Bradley A Edwards; Andrew Wellman; Scott A Sands; Robert L Owens; Danny J Eckert; David P White; Atul Malhotra Journal: Sleep Date: 2014-07-01 Impact factor: 5.849
Authors: Scott A Sands; Bradley A Edwards; Philip I Terrill; James P Butler; Robert L Owens; Luigi Taranto-Montemurro; Ali Azarbarzin; Melania Marques; Lauren B Hess; Erik T Smales; Camila M de Melo; David P White; Atul Malhotra; Andrew Wellman Journal: Eur Respir J Date: 2018-09-27 Impact factor: 16.671
Authors: Simon A Joosten; Paul Leong; Shane A Landry; Scott A Sands; Philip I Terrill; Dwayne Mann; Anthony Turton; Jhanavi Rangaswamy; Christopher Andara; Glen Burgess; Darren Mansfield; Garun S Hamilton; Bradley A Edwards Journal: Sleep Date: 2017-07-01 Impact factor: 5.849
Authors: Denise M O'Driscoll; Shane A Landry; Jonathan Pham; Alan Young; Scott A Sands; Garun S Hamilton; Bradley A Edwards Journal: Sleep Date: 2019-10-21 Impact factor: 5.849
Authors: Andrew Wellman; Bradley A Edwards; Scott A Sands; Robert L Owens; Shamim Nemati; James Butler; Chris L Passaglia; Andrew C Jackson; Atul Malhotra; David P White Journal: J Appl Physiol (1985) Date: 2013-01-24
Authors: Shane A Landry; Simon A Joosten; Luke D J Thomson; Anthony Turton; Ai-Ming Wong; Paul Leong; Philip I Terrill; Dwayne Mann; Scott A Sands; Garun S Hamilton; Bradley A Edwards Journal: Ann Am Thorac Soc Date: 2020-04
Authors: Karel G M Moons; Douglas G Altman; Johannes B Reitsma; John P A Ioannidis; Petra Macaskill; Ewout W Steyerberg; Andrew J Vickers; David F Ransohoff; Gary S Collins Journal: Ann Intern Med Date: 2015-01-06 Impact factor: 25.391